Robert Bradway

Sales & Marketing

At BIO2024 experts agreed that in a period where pharma is deeply unpopular, the industry must be proactive in telling its story.

News

Pressure is building on Amgen to withdraw rare disease therapy Tavneos, after the CHMP recommended its marketing authorisation by revoked in the EU.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.